Patrick Hawkes, MD
Plastic and Reconstructive Surgery · Cedar Rapids, IANPI 1952612616
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,723 of the $2,683 with a category attached, or 64.2%. AbbVie accounts for 79.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $1,397 and has fallen 63.4% since, to $512 in 2025.
Across 37 payments — averaging $72.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Motiva USA, LLC$185
- Integra Lifesciences Corporation$99
- Solventum Corporation$85
- Organogenesis Inc.$51
- TELA Bio, Inc.$30
- plus $90 from 5 others
What the payments were for
- Travel & lodging$96036%
- Food & beverage$1,72364%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 21 | $2,143 |
| Motiva USA, LLC | 2 | $185 |
| Integra Lifesciences Corporation | 2 | $99 |
| Solventum Corporation | 3 | $85 |
| Organogenesis Inc. | 3 | $51 |
| TELA Bio, Inc. | 1 | $30 |
| Acera Surgical, Inc. | 1 | $29 |
| Baxter Healthcare | 1 | $17 |
| Polynovo North America LLC | 1 | $16 |
| Vioptix Inc | 1 | $16 |
| Covidien LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,683 in reported general payments places this provider in the 80th percentile of 22 plastic and reconstructive surgery providers in Iowa.
See all plastic and reconstructive surgery providers in Iowa →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enoxaparin Sodium | 25 | $926 |
| Doxycycline Monohydrate | 12 | $233 |
| Ondansetron OdtOndansetron | 34 | $165 |
| Oxycodone Hcl | 42 | $139 |
| Gabapentin | 67 | $119 |
| Tramadol Hcl | 12 | $11 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Cedar Rapids
- Takintope AkinbiyiCedar Rapids$6K
- Vanessa LeonhardCedar Rapids$800
- Charles GradoCedar Rapids$139
- Rehan ZahidIowa City$57K
- Kendall KeckIowa City$6K
- Eugene ChernyDes Moines$4K
- Mark FisherIowa City$2K
- Iryna ChesnokovaIowa City$2K
- Samuel MauriceClive$2K
- Allison LorenzenIowa City$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.